E-LIB Suche - Ergebnisse für: Powles, T

1

ESMO Clinical Practice Guideline interim update on first-li..:

Powles, T. ; Bellmunt, J. ; Comperat, E....
Annals of Oncology. 35 (2024) 6 - p. 485-490 , 2024

Link: https://doi.org/10.1016/..

2

Renal cell carcinoma: ESMO Clinical Practice Guideline for ..:

Powles, T. ; Albiges, L. ; Bex, A....
Annals of Oncology. 35 (2024) 8 - p. 692-706 , 2024

Link: https://doi.org/10.1016/..

3

Prognostic significance of absolute lymphocyte count in pat..:

Takemura, K. ; Yuasa, T. ; Lemelin, A....
ESMO Open. 9 (2024) 7 - p. 103606 , 2024

Link: https://doi.org/10.1016/..

4

Penile cancer: ESMO–EURACAN Clinical Practice Guideline for..:

Muneer, A. ; Bandini, M. ; Compérat, E....
ESMO Open. 9 (2024) 7 - p. 103481 , 2024

Link: https://doi.org/10.1016/..

5

Nivolumab plus cabozantinib versus sunitinib for first-line..:

Powles, T. ; Burotto, M. ; Escudier, B....
ESMO Open. 9 (2024) 5 - p. 102994 , 2024

Link: https://doi.org/10.1016/..

6

CO68 Simulated mOS of Gemcitabine+Carboplatin ± Maintenance..:

Galsky, M.D. ; Sonpavde, G.P. ; Bloudek, B....
Value in Health. 26 (2023) 6 - p. S26-S27 , 2023

Link: https://doi.org/10.1016/..

7

Safety and efficacy of cobimetinib plus atezolizumab in pat..:

Sherman, E. ; Lee, J.L. ; Debruyne, P.R....
ESMO Open. 8 (2023) 2 - p. 100877 , 2023

Link: https://doi.org/10.1016/..

8

CO24 Simulating the Impact of First-Line Treatment Choice o..:

Galsky, M.D. ; Sonpavde, G.P. ; Bloudek, B....
Value in Health. 26 (2023) 6 - p. S18 , 2023

Link: https://doi.org/10.1016/..

9

Efficacy and safety of pembrolizumab in metastatic urotheli..:

Balar, A.V. ; Castellano, D.E. ; Grivas, P....
Annals of Oncology. 34 (2023) 3 - p. 289-299 , 2023

Link: https://doi.org/10.1016/..

10

Deferred cytoreductive nephrectomy following response to ip..:

Fransen van de Putte, E.E. ; Van Den Brink, L. ; Mansour, M....
European Urology. 83 (2023) - p. S475-S476 , 2023

Link: https://doi.org/10.1016/..

11

Tumor Response by Baseline Metastases in Patients (Pts) Wit..:

Grünwald, V. ; McKay, R.R. ; Buchler, T....
European Urology Open Science. 57 (2023) - p. S15-S16 , 2023

Link: https://doi.org/10.1016/..

12

Characterization of patients with metastatic renal cell car..:

Takemura, K. ; Ernst, M. ; Navani, V....
European Urology. 83 (2023) - p. S473-S474 , 2023

Link: https://doi.org/10.1016/..

13

Zanzalintinib (XL092) and nivolumab in non–clear cell renal..:

Suarez, C. ; Powles, T. ; Kanesvaran, R....
European Urology Open Science. 57 (2023) - p. S225 , 2023

Link: https://doi.org/10.1016/..

14

VOLGA: Results from the phase 3 safety run-in with durvalum..:

Powles, T. ; Bupathi, M ; Joshi, M....
European Urology Open Science. 45 (2022) - p. S268-S269 , 2022

Link: https://doi.org/10.1016/..

15

IMvigor010: Updated analysis of Overall Survival (OS) by ci..:

Powles, T. ; June Assaf, Z. ; Mariathasan, S....
European Urology Open Science. 45 (2022) - p. S216-S217 , 2022

Link: https://doi.org/10.1016/..